Thermo Fisher Scientific Expects Revenue Growth to Moderate in 2023
February 01 2023 - 7:18AM
Dow Jones News
By Dean Seal
Thermo Fisher Scientific Inc. expects revenue to grow by less
than 1% this year.
The scientific-equipment company said Wednesday that it is
forecasting revenue of $45.3 billion in 2023, up from $44.92
billion last year. The 2022 figure marked a 15% jump from the year
prior.
Core organic revenue, which includes the impact of revenue from
clinical research services provider PPD and excludes the impact of
all other acquisitions as well as Covid-19 testing revenue, is
expected to grow by 7%.
Adjusted earnings for the year are projected to be $23.70 a
share, the company said.
Shares edged less than 1% higher to $575 in premarket
trading.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
February 01, 2023 07:03 ET (12:03 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024
